Literature DB >> 27326070

Refractory cardiogenic shock following idiopathic giant cell myocarditis in a 19-year-old woman.

Ana Viana-Tejedor1, Iago Sousa2, Héctor Bueno2, Francisco Fernández Avilés2.   

Abstract

Entities:  

Year:  2013        PMID： 27326070      PMCID： PMC4832645          DOI： 10.1136/heartasia-2013-010279

Source DB:  PubMed          Journal:  Heart Asia        ISSN： 1759-1104


× No keyword cloud information.
  9 in total

Review 1.  Mechanical circulatory support for bridge to decision: which device and when to decide.

Authors:  Elizabeth A Ziemba; Ranjit John
Journal:  J Card Surg       Date:  2010-04-14       Impact factor: 1.620

Review 2.  Myocarditis: current trends in diagnosis and treatment.

Authors:  Jared W Magnani; G William Dec
Journal:  Circulation       Date:  2006-02-14       Impact factor: 29.690

3.  Interstitial Myocarditis Following the Clinical and Experimental Use of Sulfonamide Drugs.

Authors:  A J French; C V Weller
Journal:  Am J Pathol       Date:  1942-01       Impact factor: 4.307

4.  Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis.

Authors:  Lindsay K Murray; Jose González-Costello; Samual N Jonas; Daniel B Sims; Kerry A Morrison; Paolo C Colombo; Donna M Mancini; Susan W Restaino; Evan Joye; Evelyn Horn; Hiroo Takayama; Charles C Marboe; Yoshifumi Naka; Ulrich P Jorde; Nir Uriel
Journal:  Eur J Heart Fail       Date:  2012-01-20       Impact factor: 15.534

5.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

Review 6.  Giant cell myocarditis: diagnosis and treatment.

Authors:  L T Cooper
Journal:  Herz       Date:  2000-05       Impact factor: 1.443

7.  Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.

Authors:  Riina Kandolin; Jukka Lehtonen; Kaisa Salmenkivi; Anne Räisänen-Sokolowski; Jyri Lommi; Markku Kupari
Journal:  Circ Heart Fail       Date:  2012-11-13       Impact factor: 8.790

8.  Giant cell myocarditis as a manifestation of drug hypersensitivity.

Authors:  P R Daniels; G J Berry; H D Tazelaar; L T Cooper
Journal:  Cardiovasc Pathol       Date:  2000 Sep-Oct       Impact factor: 2.185

9.  Giant cell myocarditis triggered by a parvovirus B19 infection.

Authors:  R Dennert; S Schalla; R J van Suylen; L Eurlings; S Heymans
Journal:  Int J Cardiol       Date:  2008-02-15       Impact factor: 4.164
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.